Q2 2017 Holdings
Filed 2017-08-14 | 34 holdings | $61.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $31.4M | 2,026,998 | 51.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $24.1M | 1,990,321 | 39.5% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $3.3M | 274,196 | 5.4% |
| Anthera Pharmaceuticals Inc(ANTH) | COM | 03674U300 | $1.6M | 1,006,507 | 2.7% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $80.6K | 1,591,646 | 0.1% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $77.2K | 8,248,416 | 0.1% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $50.7K | 6,059,625 | 0.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $39.7K | 1,659,200 | 0.1% |
| Loxo Oncology Inc | COM | 548862101 | $37.2K | 463,386 | 0.1% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $33.1K | 2,970,182 | 0.1% |
| CTI Biopharma Corp(CTIC1USD) | COM NEW | 12648L601 | $28.5K | 8,596,357 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $28.2K | 1,387,853 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $25.9K | 1,856,895 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $17.7K | 3,491,933 | 0.0% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $16.0K | 3,490,077 | 0.0% |
| Tocagen Inc | COM | 888846102 | $15.4K | 1,279,078 | 0.0% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $14.9K | 17,500,000 | 0.0% |
| Oncomed Pharmaceuticals Inc | COM | 68234X102 | $14.7K | 4,400,289 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $12.4K | 7,866,108 | 0.0% |
| Cascadian Therapeutics Inc | COM NEW | 14740B606 | $11.6K | 3,133,224 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $11.1K | 3,518,830 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $10.5K | 1,502,800 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $9.2K | 7,400,128 | 0.0% |
| Spring BK Pharmaceuticals Inc | COM | 849431101 | $8.3K | 615,384 | 0.0% |
| Ignyta Inc | COM | 451731103 | $7.2K | 700,000 | 0.0% |
| Nivalis Therapeutics Inc | COM | 65481J109 | $6.4K | 2,644,806 | 0.0% |
| GTX Inc del | COM NEW | 40052B207 | $5.9K | 1,108,433 | 0.0% |
| Orexigen Therapeutics Inc | NOTE 2.750% | 686164AB0 | $5.0K | $10,000,000 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $4.8K | 1,770,692 | 0.0% |
| Aduro Biotech Inc(ADROEUR) | COM | 00739L101 | $3.4K | 300,000 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $3.2K | 3,278,900 | 0.0% |
| Orexigen Therapeutics Inc | COM NEW | 686164302 | $2.1K | 734,976 | 0.0% |
| Pain Therapeutics Inc | COM NEW | 69562K506 | $1.3K | 325,508 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $1.3K | 391,386 | 0.0% |